These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Ketorolac protection in damage due to myocardial ischemia and reperfusion]. Pichardo J; Chávez R; Bravo C; Zazueta C; Chávez E Arch Inst Cardiol Mex; 1994; 64(4):325-30. PubMed ID: 7840715 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. Jett MF; Ramesha CS; Brown CD; Chiu S; Emmett C; Voronin T; Sun T; O'Yang C; Hunter JC; Eglen RM; Johnson RM J Pharmacol Exp Ther; 1999 Mar; 288(3):1288-97. PubMed ID: 10027870 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the intracellular Ca(2+) pools involved in the calcium homeostasis in Herpetomonas sp. promastigotes. Sodré CL; Moreira BL; Nobrega FB; Gadelha FR; Meyer-Fernandes JR; Dutra PM; Vercesi AE; Lopes AH; Scofano HM; Barrabin H Arch Biochem Biophys; 2000 Aug; 380(1):85-91. PubMed ID: 10900136 [TBL] [Abstract][Full Text] [Related]
5. Ketorolac causes the release of methionine-enkephalin in rats. Michel RE; Holt JC; Domer FR Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):249-52. PubMed ID: 8832917 [TBL] [Abstract][Full Text] [Related]
6. Prooxidants open both the mitochondrial permeability transition pore and a low-conductance channel in the inner mitochondrial membrane. Kushnareva YE; Sokolove PM Arch Biochem Biophys; 2000 Apr; 376(2):377-88. PubMed ID: 10775426 [TBL] [Abstract][Full Text] [Related]
7. Is the inhibition of oxidative phosphorylation chains in kidney mitochondria responsible for cyclosporine nephrotoxicity? Zenatti M; Aupetit B; Ghazzi A; Shechter E; Michel A; Nataf V; Aymard P; Legrand JC Transplant Proc; 1988 Jun; 20(3 Suppl 3):700-4. PubMed ID: 3388507 [No Abstract] [Full Text] [Related]
8. Antiinflammatory drug effects on bone repair and remodeling in rabbits. Ho ML; Chang JK; Wang GJ Clin Orthop Relat Res; 1995 Apr; (313):270-8. PubMed ID: 7641490 [TBL] [Abstract][Full Text] [Related]
12. Oxidative phosphorylation and mitochondrial physiology: a critical review of chemiosmotic theory, and reinterpretation by the association-induction hypothesis. Ling GN Physiol Chem Phys; 1981; 13(1):29-96. PubMed ID: 7022492 [TBL] [Abstract][Full Text] [Related]
14. [Clinical use of ketorolac (ketrodole) for analgesia in the early postoperative period]. Lebedeva RN; Nikoda VV; Petrov RO Anesteziol Reanimatol; 1995; (1):29-31. PubMed ID: 7605030 [TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. Gerstenfeld LC; Thiede M; Seibert K; Mielke C; Phippard D; Svagr B; Cullinane D; Einhorn TA J Orthop Res; 2003 Jul; 21(4):670-5. PubMed ID: 12798067 [TBL] [Abstract][Full Text] [Related]
16. Unaltered hepatic oxidative phosphorylation and mitochondrial permeability transition in wistar rats treated with nimesulide: Relevance for nimesulide toxicity characterization. Moreno AJ; Oliveira PJ; Nova CD; Alvaro AR; Moreira RA; Santos SM; Macedo T J Biochem Mol Toxicol; 2007; 21(2):53-61. PubMed ID: 17427176 [TBL] [Abstract][Full Text] [Related]
17. Renal hemodynamic effects of chronic ketorolac tromethamine treatment in aged lean and obese Zucker rats. Alavi FK; Zawada ET; Hoff KK Clin Nephrol; 1995 May; 43(5):318-23. PubMed ID: 7634547 [TBL] [Abstract][Full Text] [Related]
18. Cepharanthine, an anti-inflammatory drug, suppresses mitochondrial membrane permeability transition. Nagano M; Kanno T; Fujita H; Muranaka S; Fujiwara T; Utsumi K Physiol Chem Phys Med NMR; 2003; 35(2):131-43. PubMed ID: 15552724 [TBL] [Abstract][Full Text] [Related]